Clinical Trial Update: Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating EFV-TDF-FTC and AZT-3TC-LPV/r regimens for preventing mother-to-child transmission of HIV in pregnant and breastfeeding women has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• AZT-3TC-LPV/r
• EFV-TDF-FTC

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infection, Pregnancy | Phase 3 | Status: WITHDRAWN